Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-26 @ 2:35 AM
Study NCT ID:
NCT00434759
Status:
COMPLETED
Last Update Posted:
2012-11-28
First Post:
2007-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Social Phobia Intervention Study of Mannheim
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000072861', 'term': 'Phobia, Social'}], 'ancestors': [{'id': 'D010698', 'term': 'Phobic Disorders'}, {'id': 'D001008', 'term': 'Anxiety Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D015928', 'term': 'Cognitive Behavioral Therapy'}, {'id': 'D060986', 'term': 'Water Wells'}], 'ancestors': [{'id': 'D001521', 'term': 'Behavior Therapy'}, {'id': 'D011613', 'term': 'Psychotherapy'}, {'id': 'D004191', 'term': 'Behavioral Disciplines and Activities'}, {'id': 'D014881', 'term': 'Water Supply'}, {'id': 'D012498', 'term': 'Sanitary Engineering'}, {'id': 'D004738', 'term': 'Engineering'}, {'id': 'D013676', 'term': 'Technology, Industry, and Agriculture'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'martin.bohus@zi-mannheim.de', 'phone': '+49 621 1703 4002', 'title': 'Prof. Martin Bohus', 'organization': 'Central Institute of Mental Health, Mannheim, Germany'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'description': 'No serious and/or other adverse events were assessed.', 'eventGroups': [{'id': 'EG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission', 'otherNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)', 'otherNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Change From Baseline in Social Interaction Anxiety Scale (SIAS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to 24 sessions)'}, {'id': 'OG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only; 16 sessions)'}], 'classes': [{'title': 'baseline', 'categories': [{'measurements': [{'value': '43.13', 'spread': '14.26', 'groupId': 'OG000'}, {'value': '48.94', 'spread': '11.00', 'groupId': 'OG001'}]}]}, {'title': 'post-treatment', 'categories': [{'measurements': [{'value': '34.85', 'spread': '14.86', 'groupId': 'OG000'}, {'value': '33.35', 'spread': '16.90', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.05', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciPctValue': '95', 'paramValue': '5.82', 'pValueComment': 'priori threshold for statistical significance is 0.05 p-value is not adjusted for multiple comparisons', 'estimateComment': 'The reported interaction effect is significant (p\\< .05) in favour of standard therapy.', 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'We report the interaction effect.', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intention-to-Treat'}, {'type': 'SECONDARY', 'title': 'Change From Baseline in Brief Symptom Inventory (BSI)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'OG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}], 'classes': [{'title': 'baseline', 'categories': [{'measurements': [{'value': '1.00', 'spread': '0.59', 'groupId': 'OG000'}, {'value': '0.90', 'spread': '0.56', 'groupId': 'OG001'}]}]}, {'title': 'post-treatment', 'categories': [{'measurements': [{'value': '0.71', 'spread': '0.51', 'groupId': 'OG000'}, {'value': '0.51', 'spread': '0.51', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.05', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciPctValue': '95', 'paramValue': '1.24', 'pValueComment': 'priori threshold for statistical significance is 0.05 p-value ist not adjusted for multiple comparisons', 'estimateComment': 'The reported interaction effect is not significant.', 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'we report the interaction effect', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intention-to-Treat'}, {'type': 'SECONDARY', 'title': 'Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'OG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}], 'classes': [{'title': 'baseline', 'categories': [{'measurements': [{'value': '21.48', 'spread': '9.97', 'groupId': 'OG000'}, {'value': '21.47', 'spread': '11.04', 'groupId': 'OG001'}]}]}, {'title': 'post-treatment', 'categories': [{'measurements': [{'value': '16.20', 'spread': '10.26', 'groupId': 'OG000'}, {'value': '14.28', 'spread': '9.93', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.05', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciPctValue': '95', 'paramValue': '0.99', 'pValueComment': 'p-value is not adjusted for multiple comparisons', 'estimateComment': 'The reported interaction effect is not significant.', 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'we report the interaction effect', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intention-to-Treat'}, {'type': 'PRIMARY', 'title': 'Change From Baseline in Social Phobia Scale (SPS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'OG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}], 'classes': [{'title': 'baseline', 'categories': [{'measurements': [{'value': '35.85', 'spread': '14.97', 'groupId': 'OG000'}, {'value': '33.95', 'spread': '13.12', 'groupId': 'OG001'}]}]}, {'title': 'post-treatment', 'categories': [{'measurements': [{'value': '24.89', 'spread': '17.41', 'groupId': 'OG000'}, {'value': '17.58', 'spread': '13.36', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.05', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciPctValue': '95', 'paramValue': '3.43', 'pValueComment': 'priori threshold for statistical significance is 0.05 p-value ist not adjusted for multiple comparisons', 'estimateComment': 'The reported interaction is not significant.', 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'we report the interaction effect', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intention-to-Treat'}, {'type': 'PRIMARY', 'title': 'Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'OG000'}, {'value': '43', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'OG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}], 'classes': [{'title': 'baseline', 'categories': [{'measurements': [{'value': '57.46', 'spread': '23.61', 'groupId': 'OG000'}, {'value': '60.58', 'spread': '19.37', 'groupId': 'OG001'}]}]}, {'title': 'post-treatment', 'categories': [{'measurements': [{'value': '41.22', 'spread': '23.49', 'groupId': 'OG000'}, {'value': '31.84', 'spread': '21.57', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.05', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Mean Difference (Final Values)', 'ciPctValue': '95', 'paramValue': '6.86', 'pValueComment': 'priori threshold for statistical significance ist 0.05 p-value ist nor adjusted for multiple comparisons', 'estimateComment': 'The reported interaction effect is significant (p \\< .05) in favour of standard therapy', 'statisticalMethod': 'ANOVA', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'we report the interaction effect', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.', 'unitOfMeasure': 'units on a scale', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Intention-to-Treat'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'FG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '46'}, {'groupId': 'FG001', 'numSubjects': '43'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '22'}, {'groupId': 'FG001', 'numSubjects': '38'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '24'}, {'groupId': 'FG001', 'numSubjects': '5'}]}], 'dropWithdraws': [{'type': 'Lack of Efficacy', 'reasons': [{'groupId': 'FG000', 'numSubjects': '5'}, {'groupId': 'FG001', 'numSubjects': '4'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '1'}]}, {'type': 'family affairs', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '46', 'groupId': 'BG000'}, {'value': '43', 'groupId': 'BG001'}, {'value': '89', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Stepped Care Program', 'description': 'stepped-care program with self-help module with minimal therapist contact as first step, followed by therapist-guided intervention depending on status of remission'}, {'id': 'BG001', 'title': 'Standardtherapy', 'description': 'standard therapy (therapist-guided intervention only)'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Categorical', 'classes': [{'categories': [{'title': '<=18 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Between 18 and 65 years', 'measurements': [{'value': '46', 'groupId': 'BG000'}, {'value': '43', 'groupId': 'BG001'}, {'value': '89', 'groupId': 'BG002'}]}, {'title': '>=65 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Age Continuous', 'classes': [{'categories': [{'measurements': [{'value': '37.26', 'spread': '10.47', 'groupId': 'BG000'}, {'value': '38.47', 'spread': '10.26', 'groupId': 'BG001'}, {'value': '37.84', 'spread': '10.33', 'groupId': 'BG002'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '24', 'groupId': 'BG000'}, {'value': '24', 'groupId': 'BG001'}, {'value': '48', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '22', 'groupId': 'BG000'}, {'value': '19', 'groupId': 'BG001'}, {'value': '41', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'Germany', 'categories': [{'measurements': [{'value': '46', 'groupId': 'BG000'}, {'value': '43', 'groupId': 'BG001'}, {'value': '89', 'groupId': 'BG002'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 89}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2006-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2012-10', 'completionDateStruct': {'date': '2011-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2012-10-28', 'studyFirstSubmitDate': '2007-02-09', 'resultsFirstSubmitDate': '2011-11-29', 'studyFirstSubmitQcDate': '2007-02-09', 'lastUpdatePostDateStruct': {'date': '2012-11-28', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2012-10-28', 'studyFirstPostDateStruct': {'date': '2007-02-13', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2012-11-28', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2009-05', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change From Baseline in Social Interaction Anxiety Scale (SIAS)', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.'}, {'measure': 'Change From Baseline in Social Phobia Scale (SPS)', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.'}, {'measure': 'Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.'}], 'secondaryOutcomes': [{'measure': 'Change From Baseline in Brief Symptom Inventory (BSI)', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.'}, {'measure': 'Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)', 'timeFrame': 'baseline to post-treatment (on average 24 weeks)', 'description': 'The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['randomized controlled trial', 'stepped-care program', 'cognitive therapy of social phobia according to D.M. Clark'], 'conditions': ['Social Phobia']}, 'descriptionModule': {'briefSummary': 'Primary objective:\n\nThe purpose of this study is to examine efficacy and efficiency of a Stepped Care Program (SCP) for patients with Social Phobia in comparison to the standard cognitive therapy for Social Phobia according to D.M. Clark.\n\nSecondary objective:\n\nFurther, it is intended to identify mechanisms of change which mediate treatment outcome and to identify differential predictors for therapy success for the two treatment conditions.', 'detailedDescription': 'With prevalence rates (lifetime) up to 13% in western countries, Social Phobia is one of the most frequent mental disorders. Main objective of this clinical trial is the evaluation of the efficacy and efficiency of a stepped care program for patients with Social Phobia (SCP) as compared to a standard therapy (ST) for patients with social phobia. Both interventions are based on the cognitive therapy according to D.M. Clark.\n\nThe SCP starts with a 8-sessions self-help-module with minimal therapist contact via email. Patients who do not reach remission after this first step, enter step 2 which consists of 8 therapy sessions guided by a therapist. If patients are not remitted after that, they receive another 8 sessions of therapist-guided cognitive treatment in step 3. So the SCP contains 8, 16 or 24 sessions of therapy - depending on remission status of the patient. In contrast to that, the ST comprises 16 sessions of therapist-guided intervention.\n\nThe diagnostic status of the patients is assessed by blinded clinician raters before treatment, after every eighth therapy session, and at 5 follow-up timepoints in order to examine the stability of treatment effects (3, 6, 9, 12 and 30 months after the end of therapy). Besides efficacy and efficiency of the SCP vs. ST, mechanisms of change and differential predictors for therapy outcome will be investigated.\n\nHypotheses: We expect that\n\n1. the SCP is significantly more effective than the ST.\n2. the SCP is significantly more efficient than the ST.\n3. the results referring to the efficacy will be stable up to 30 months after the end of treatment(Follow Up Phase).\n4. the SCP will cause less primary and secondary costs than the ST.\n5. successful therapy leads to an improvement in the following areas:\n\n * reduction of biased information processing,\n * reduction of negative thoughts, subjective anxiety, safety behaviors, self-focused attention and autonomic arousal in anxiety-provoking situations,\n * amelioration of verbal and non-verbal social competence in anxiety- provoking situations.\n\nAs mediators of change, the factors maintaining social anxiety according to the model of Social Phobia by Clark and Wells (1995) will be investigated.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Diagnosis of Social Phobia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV)\n* Duration of the disorder at least 1 year\n* Severity of symptomatology according to at least one of two self-report measures for social anxiety above Cut-Off: Social Interaction Anxiety Scale (SIAS: value of 26 or more) and / or Social Phobia Scale (SPS: value of 17 or more)\n* Age: 18-60\n* Written Informed Consent\n\nExclusion Criteria:\n\n* Social Phobia is not the main diagnosis\n* Mental Retardation\n* Lifetime Diagnoses: Schizophreniform Disorder, Bipolar Affective Disorder\n* Acute Diagnoses: severe Major Depression Episode, severe Anorexia Nervosa, Substance-, Drug - or Alcohol-Dependence, life-threatening suicidal crisis\n* Psychotropic medication (except stable treatment with antidepressant since 3 months before study start: medication and dosage has to be stable during the entire study duration)'}, 'identificationModule': {'nctId': 'NCT00434759', 'briefTitle': 'Social Phobia Intervention Study of Mannheim', 'organization': {'class': 'OTHER', 'fullName': 'Central Institute of Mental Health, Mannheim'}, 'officialTitle': 'Evaluation of the Efficacy, Mechanisms of Change and Efficiency of a Stepped-care Program With a Computer-based Self-help Module and Minimal Therapist Contact in Comparison to a Standard Cognitive Therapy for Patients With Social Phobia', 'orgStudyIdInfo': {'id': 'SP-32000'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'SCP', 'description': 'SCP is a stepped-care program with a self-help module with minimal therapist contact (8 sessions) as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to a maximum of 16 sessions).', 'interventionNames': ['Behavioral: stepped care program based on cognitive therapy']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'ST', 'description': 'A standard therapy which means a therapist-guided intervention with 16 sessions face-to-face therapy.', 'interventionNames': ['Behavioral: cognitive therapy']}], 'interventions': [{'name': 'cognitive therapy', 'type': 'BEHAVIORAL', 'otherNames': ['cognitive therapy of social phobia according to D.M. Clark'], 'description': 'changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments', 'armGroupLabels': ['ST']}, {'name': 'stepped care program based on cognitive therapy', 'type': 'BEHAVIORAL', 'otherNames': ['based on cognitive therapy for social phobie by Clark & Wells (1995)'], 'description': 'starting with a digital-video-disk-based (DVD-based) self-help module (8 Sessions) followed by face-to-face-therapy including 8 or 16 sessions depending on remission status; including: changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments', 'armGroupLabels': ['SCP']}]}, 'contactsLocationsModule': {'locations': [{'zip': '68159', 'city': 'Mannheim', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'Central Institute of Mental Health', 'geoPoint': {'lat': 49.4891, 'lon': 8.46694}}], 'overallOfficials': [{'name': 'Martin Bohus, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Central Institute of Mental Health in Mannheim'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Central Institute of Mental Health, Mannheim', 'class': 'OTHER'}, 'collaborators': [{'name': 'German Research Foundation', 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}